These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 26209736

  • 1. RNA expression signatures and posttranscriptional regulation in diabetic nephropathy.
    Rudnicki M, Beckers A, Neuwirt H, Vandesompele J.
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv35-42. PubMed ID: 26209736
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.
    Gholaminejad A, Abdul Tehrani H, Gholami Fesharaki M.
    J Nephrol; 2018 Dec; 31(6):813-831. PubMed ID: 30019103
    [Abstract] [Full Text] [Related]

  • 4. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R.
    PLoS One; 2016 Dec; 11(3):e0150154. PubMed ID: 26930277
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S, Bhattacharjee N.
    Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
    Zanchi C, Macconi D, Trionfini P, Tomasoni S, Rottoli D, Locatelli M, Rudnicki M, Vandesompele J, Mestdagh P, Remuzzi G, Benigni A, Zoja C.
    Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
    Liu Y, Li H, Liu J, Han P, Li X, Bai H, Zhang C, Sun X, Teng Y, Zhang Y, Yuan X, Chu Y, Zhao B.
    J Am Soc Nephrol; 2017 Dec; 28(12):3627-3638. PubMed ID: 28923913
    [Abstract] [Full Text] [Related]

  • 12. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy.
    Kang WL, Xu GS.
    Sci Rep; 2016 Jan 27; 6():19979. PubMed ID: 26813039
    [Abstract] [Full Text] [Related]

  • 13. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S, Matboli M, Bekhet MM.
    Biomed Pharmacother; 2016 Oct 27; 83():92-99. PubMed ID: 27470555
    [Abstract] [Full Text] [Related]

  • 14. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
    McClelland AD, Herman-Edelstein M, Komers R, Jha JC, Winbanks CE, Hagiwara S, Gregorevic P, Kantharidis P, Cooper ME.
    Clin Sci (Lond); 2015 Dec 27; 129(12):1237-49. PubMed ID: 26415649
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
    Kato M, Natarajan R.
    Ann N Y Acad Sci; 2015 Sep 27; 1353(1):72-88. PubMed ID: 25877817
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
    Zhou Z, Wan J, Hou X, Geng J, Li X, Bai X.
    Cell Death Dis; 2017 Mar 09; 8(3):e2658. PubMed ID: 28277542
    [Abstract] [Full Text] [Related]

  • 18. Identification of C3 as a therapeutic target for diabetic nephropathy by bioinformatics analysis.
    Tang S, Wang X, Deng T, Ge H, Xiao X.
    Sci Rep; 2020 Aug 10; 10(1):13468. PubMed ID: 32778679
    [Abstract] [Full Text] [Related]

  • 19. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
    Sankrityayan H, Kulkarni YA, Gaikwad AB.
    Pharmacol Res; 2019 Mar 10; 141():574-585. PubMed ID: 30695734
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.
    Duan LJ, Ding M, Hou LJ, Cui YT, Li CJ, Yu DM.
    Biochem Biophys Res Commun; 2017 Mar 11; 484(3):598-604. PubMed ID: 28137588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.